AAAAAA

   
Results: 1-9 |
Results: 9
Gene therapy attenuates the elevated blood pressure and glucose intolerance in an insulin-resistant model of hypertension
Authors: Katovich, MJ Reaves, PY Francis, SC Pachori, AS Wang, HW Raizada, MK
Citation: Mj. Katovich et al., Gene therapy attenuates the elevated blood pressure and glucose intolerance in an insulin-resistant model of hypertension, J HYPERTENS, 19(9), 2001, pp. 1553-1558
Attenuation of hypertension by systemic delivery of retroviral vector containing type I angiotensin II receptor antisense cDNA
Authors: Reaves, PY Wang, HW Katovich, MJ Gelband, CH Raizada, MK
Citation: Py. Reaves et al., Attenuation of hypertension by systemic delivery of retroviral vector containing type I angiotensin II receptor antisense cDNA, METHODS, 22(3), 2000, pp. 211-218
Targeting of the renin-angiotensin system by antisense gene therapy: a possible strategy for the long-term control of hypertension
Authors: Raizada, MK Francis, SC Wang, HW Gelband, CH Reaves, PY Katovich, MJ
Citation: Mk. Raizada et al., Targeting of the renin-angiotensin system by antisense gene therapy: a possible strategy for the long-term control of hypertension, J HYPERTENS, 18(4), 2000, pp. 353-362
Angiotensin I-converting enzyme antisense gene therapy causes permanent antihypertensive effects in the SHR
Authors: Wang, HW Reaves, PY Gardon, ML Keene, K Goldberg, DS Gelband, CH Katovich, MJ Raizada, MK
Citation: Hw. Wang et al., Angiotensin I-converting enzyme antisense gene therapy causes permanent antihypertensive effects in the SHR, HYPERTENSIO, 35(1), 2000, pp. 202-208
Angiotensin I-converting enzyme antisense prevents altered renal vascular reactivity, but not high blood pressure, in spontaneously hypertensive rats
Authors: Gelband, CH Wang, HW Gardon, ML Keene, K Goldberg, DS Reaves, PY Katovich, MJ Raizada, MK
Citation: Ch. Gelband et al., Angiotensin I-converting enzyme antisense prevents altered renal vascular reactivity, but not high blood pressure, in spontaneously hypertensive rats, HYPERTENSIO, 35(1), 2000, pp. 209-213
Retrovirally mediated delivery of angiotensin II type 1 receptor antisensein vitro and in vivo
Authors: Wang, HW Lu, D Reaves, PY Katovich, MJ Raizada, MK
Citation: Hw. Wang et al., Retrovirally mediated delivery of angiotensin II type 1 receptor antisensein vitro and in vivo, METH ENZYM, 314, 2000, pp. 581-590
Angiotensin II type 1 receptor antisense gene therapy prevents altered renal vascular calcium homeostasis in hypertension
Authors: Gelband, CH Reaves, PY Evans, J Wang, HW Katovich, MJ Raizada, MK
Citation: Ch. Gelband et al., Angiotensin II type 1 receptor antisense gene therapy prevents altered renal vascular calcium homeostasis in hypertension, HYPERTENSIO, 33(1), 1999, pp. 360-365
Sustained inhibition of angiotensin I-converting enzyme (ACE) expression and long-term antihypertensive action by virally mediated delivery of ACE antisense cDNA
Authors: Wang, HW Katovich, MJ Gelband, CH Reaves, PY Phillips, MI Raizada, MK
Citation: Hw. Wang et al., Sustained inhibition of angiotensin I-converting enzyme (ACE) expression and long-term antihypertensive action by virally mediated delivery of ACE antisense cDNA, CIRCUL RES, 85(7), 1999, pp. 614-622
Permanent cardiovascular protection from hypertension by the AT(1) receptor antisense gene therapy in hypertensive rat offspring
Authors: Reaves, PY Gelband, CH Wang, HW Yang, H Berecek, KH Katovich, MJ Raizada, MK
Citation: Py. Reaves et al., Permanent cardiovascular protection from hypertension by the AT(1) receptor antisense gene therapy in hypertensive rat offspring, CIRCUL RES, 85(10), 1999, pp. E44-E50
Risultati: 1-9 |